FibroGen (FGEN) Misses Q2 EPS by 100c

August 9, 2021 4:32 PM EDT

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($1.45), $1.00 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $24.4 million versus the consensus estimate of $71.38 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities